Interleukin-10 Released by CD4 + CD25 + Natural Regulatory T Cells Improves Microvascular Endothelial Function Through Inhibition of NADPH Oxidase Activity in Hypertensive Mice

Natural Regulatory T Cells Control Coronary Arteriolar Endothelial Dysfunction in Hypertensive Mice

(2011) Khalid Matrougui et al.   AMERICAN JOURNAL OF PATHOLOGY

Fk506 Binding Protein 12 Deficiency in Endothelial and Hematopoietic Cells Decreases Regulatory T Cells and Causes Hypertension

(2011) Valorie L. Chiasson et al.   HYPERTENSION

Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats

(2010) John H. Tinsley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice

(2010) Ali H Amin et al.   LABORATORY INVESTIGATION

Valsartan Improves Endothelial Dysfunction in Hypertension: A Randomized, Double-Blind Study

(2009) Nikolaos Tzemos et al.   Cardiovascular Therapeutics

Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C

(2009) Ana Fortuño et al.   HYPERTENSION

Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction

(2009) Sean P. Didion et al.   HYPERTENSION

Cytokine network and T cell immunity in atherosclerosis

(2009) Hafid Ait-Oufella et al.   Seminars in Immunopathology

Inflammation and cortisol response in coronary artery disease

(2008) Johnny Nijm et al.   ANNALS OF MEDICINE

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice

(2008) S. Belmadani et al.   DIABETES

Angiotensin II-Induced Hypertension Is Associated with a Selective Inhibition of Endothelium-Derived Hyperpolarizing Factor-Mediated Responses in the Rat Mesenteric Artery

(2008) S. Dal-Ros et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant

(2007) Sabine Heumüller et al.   HYPERTENSION